Close

Analyst Ratings for Agile Therapeutics (AGRX) [Neutrals]

AGRX Rating Summary

AGRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AGRX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.00 (+1900%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 80%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/18/2024 Maxim Group Naz Rahman Downgrade Hold
(Buy)
N/A
(N/A)
0.54
(0.60)
11.11% Details
2/2/2021 Piper Sandler Edward Tenthoff Downgrade Neutral
(Overweight)
303.00
(300.00)
2.81
(0.60)
-78.65% Details